Carmel Wroth
Carmel Wroth is a senior health editor for NPR's Science Desk, where she guides digital strategy for the health team and conceives and edits digital-first, enterprise stories and packages.
Formerly, she founded and managed Side Effects Public Media, a public radio collaborative covering public health in the Midwest. Wroth also served as an editor at Yoga Journal for five years.
-
New estimates say the U.S. needs to triple its testing. But how much testing does each state need? Here's how states compare to each other, and to targets experts say they should hit. -
The preliminary results showed that hospitalized patients who received remdesivir recovered 31% faster. Dr. Anthony Fauci hailed the findings as "quite good news." -
There are rumblings that U.S. health officials may start encouraging Americans to wear face masks to cut down on asymptomatic spread. But with continued shortages, it's not clear how we'd do that. -
Federal agencies are working furiously to find out what is causing people to sicken and are warning consumers not to vape. -
With hundreds of unexplained cases of vaping-related illness, and the sharp rise in youth vaping, the Trump administration is acting to crack down on kid-friendly vape flavors. -
President Trump has signed an executive order pushing for sweeping changes in the way kidney disease is treated. -
The World Health Organization has updated its handbook of diseases to include an expanded definition of burnout. It closely links it to workplace stress and says it can lead to reduced productivity. -
A federal agency issued a proposed rule Friday that rolls back Obama-era protections for transgender patients. Advocates for transgender people say the rule leaves them vulnerable to discrimination. -
In That Good Night, palliative care doctor Sunita Puri shares insights from her years caring for patients with serious illness. She sees her role as an advocate and ally — every step of the way. -
Gottlieb, who will resign in a month, stood out in the Trump administration for his efforts to regulate the tobacco and pharmaceutical industries. The reasons for his resignation are not yet clear.